Keywords: Belgium, Pharmaceutical market forecast, Drug cost-cutting, Patient access

Slow growth seen for Belgium pharma market, which will be worth $6.77 billion in 2014

Article | 16 December 2009

Growth in the Belgian drug market is expected to decline in 2009, with pharmaceutical expenditure calculated to increase by only 2.41% by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in